Evaluation of the safety, pharmacokinetics and treatment effects of an ανβ3 integrin inhibitor on bone turnover and disease activity in men with hormone‐refractory prostate cancer and bone metastases
暂无分享,去创建一个
M. Campone | M. Rosenthal | A. Lombardi | A. Mehta | Weili He | F. Rolland | L. Xue | T. Han | Peter Davidson | Y. Berd